Ritsushi Kato
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (25)
Year:
2026
Year:
2026
Background In some patients, transcatheter aortic valve implantation (TAVI) is associated with conduction disturbances, necessitating permanent pacemaker implantation (PMI). The clinical course of conduction disturbances after PMI, based on the type of TAVI valve, remains unclear. Therefore, the present study aimed to evaluate the effects of different types of TAVI valves on the clinical course of conduction disturbances. Methods In total, 480 patients, including 230 with self‐expandable (SE) valves and 250 with balloon‐expandable (BE) valves, who underwent TAVI between January 2016 and December 2024, were enrolled in this study. The characteristics of patients who required PMI and the changes in the ventricular pacing ratio were compared. Results There was no significant difference in PMI factors depending on the type of valve. Computed tomography (CT) images showed that the length of the membranous septum (MS) in the PMI group did not differ from the length of the MS in the non‐PMI group. There was a significant difference in improvement in autologous AV conduction between the SE and BE groups at PMI time (SE group vs. BE group; 11/15 [66.7%] vs. 3/11 [27.3%], p = 0.047). At 1 month follow‐up, the SE group improved significantly compared to the BE group (SE vs. BE; 14/15 [93.3%] vs. 4/11 [33.3%], p = 0.002). Conclusion Restoration of autologous AV conduction and subsequent decrease in ventricular pacing ratio were more likely in the SE group and less variable in the BE group. This result indicates that PM dependency can be reduced by using an extended AVD setting or AVH.
Year:
2026
Year:
2026
Background The relationship between oral anticoagulant (OAC) status after catheter ablation (CA) for atrial fibrillation (AF) and the risks of ischemic stroke or major bleeding events is still unknown. Methods This is a subanalysis of the RYOUMA registry, a prospective multicenter observational study of Japanese patients who underwent CA for AF in 2017–2018. Results Of the 2844 patients, the rate of DOAC continuation was 48.1%, 69.6%, and 80.9% in patients with a CHADS2 score of 0–1, 2, and 3–6, respectively. Among the patients taking DOACs with a CHADS2 score of 0–1 and 2, the incidence rates of major bleeding were significantly higher than those of ischemic stroke or systemic embolic events (SEEs) (1.3%/year [95% CI, 0.6–2.1] vs. 0.3%/year [95% CI, 0.0–0.7], p = 0.019; 1.8%/year [95% CI, 0.6–3.0] vs. 0.2%/year [95% CI, 0.0–0.6], p = 0.018, respectively). However, there was no difference between the incidence rates of major bleeding events and ischemic stroke or SEEs in patients taking DOACs with a CHADS2 score of 3–6 (1.6%/year [95% CI, 0.2–3.0] vs. 1.0%/year [95% CI, 0.0–2.1], p = 0.474). Conclusions In patients with a CHADS2 score of 2, those who continued taking DOACs had a higher incidence rate of major bleeding events compared to ischemic stroke/SEEs, similar to those with a CHADS2 score of 0–1. Conversely, in patients with a CHADS2 score of 3–6, the incidence rates of both ischemic stroke/SEEs and major bleeding were similarly high. Trial Registration: The study was registered as UMIN000026092 (University Hospital Medical Information Network‐Clinical Trial Registry)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Collaborators (23)
Andrea Natale
Docenti di ruolo di Ia fascia
University of Rome Tor Vergata
Naotaka Hashiguchi
Takamatsu Red Cross Hospital
Teruyuki Hirano
Professor and Chairman
Kyorin University
Hideo Fujita
professor
Jichi Medical University Saitama Medical Center
Hidehira Fukaya
Junior Associate Professor
Kitasato University School of Medicine
Takeshi Kato
Kanazawa University
Atsuhiko Yagishita
Tokai University
Hirofumi Tomita
-
Yuki Komatsu
Lecturer
University of Tsukuba
Morio Shoda
Professor
Tokyo Women's Medical University
Akihiko Nogami
Professor
University of Tsukuba
Shiro Nakahara
Associate professor
Jichi Medical University Saitama Medical Center
Kyoko Soejima
-
Akihiro Yoshitake
Saitama Medical University
Hiroshi Morita
Professor
-
Shingen Owada
Iwate Medical University
Scott Kasner
Professor, Clinician-Educator
University of Pennsylvania
Alpesh N Amin
University of California, Irvine
Teiichi Yamane
-
Kentaro Minami
Associate Professor
Dokkyo Medical University
Kosuke Muto
National Cerebral and Cardiovascular Center
Yasuo Okumura
-
Tetsuo Sasano
-
Make your next move.
Prepare your application
Review drafts before you send them.